Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANIFROLUMAB for Dermatomyositis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where ANIFROLUMAB was used for Dermatomyositis.

Most Reported Side Effects for ANIFROLUMAB

Side Effect Reports % Deaths Hosp.
Off label use 33 8.9% 1 8
Systemic lupus erythematosus 31 8.4% 1 7
Drug ineffective 26 7.0% 0 5
Fatigue 19 5.1% 0 3
Arthralgia 18 4.9% 0 2
Pyrexia 18 4.9% 0 9
Covid-19 17 4.6% 0 6
Cough 16 4.3% 0 5
Headache 16 4.3% 0 4
Lupus nephritis 16 4.3% 0 1
Nausea 16 4.3% 0 5
Pain 16 4.3% 0 5
Treatment failure 15 4.0% 0 0
Herpes zoster 14 3.8% 1 2
Inappropriate schedule of product administration 14 3.8% 0 4

Other Indications for ANIFROLUMAB

Systemic lupus erythematosus (250) Autoantibody positive (41) Chronic cutaneous lupus erythematosus (13) Lupus nephritis (11) Product used for unknown indication (5)

Other Drugs Used for Dermatomyositis

RITUXIMAB (993) METHOTREXATE (958) HUMAN IMMUNOGLOBULIN G (913) PREDNISONE (744) PREDNISOLONE (652) METHYLPREDNISOLONE (647) MYCOPHENOLATE MOFETIL (636) TACROLIMUS (626) CYCLOPHOSPHAMIDE (511) HYDROXYCHLOROQUINE (419)

Related Pages

ANIFROLUMAB Full Profile All Dermatomyositis Drugs ANIFROLUMAB Demographics ANIFROLUMAB Timeline